Novel Pyridone Carboxamide Derived Compounds as Soluble Epoxide Hydrolase Inhibitors for Treating Diabetic Retinopathy

Key Points

• The research aims to develop and evaluate new compounds that inhibit soluble epoxide hydrolase for treating diabetic retinopathy.
• Synthesize novel pyridone carboxamide derived compounds.
• Test the inhibitory effects of these compounds on soluble epoxide hydrolase.
• Explore pharmaceutical compositions for potential therapeutic use.
• Identified new compounds with effective inhibition of soluble epoxide hydrolase.
• Demonstrated potential for these inhibitors to treat diabetic retinopathy.